421 – 430 of 2803
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Adverse skin reactions following different types of mask usage during the COVID-19 pandemic
- Contribution to journal › Letter
-
Mark
NTRK Alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets
- Contribution to journal › Letter
-
Mark
Multiple-Biomarker Panel Estimated GFR Is Not Optimal or Cost-Effective
- Contribution to journal › Letter
-
Mark
European Task Force on Atopic Dermatitis : position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
- Contribution to journal › Letter
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
- Contribution to journal › Letter
-
Mark
Sex differences in Lemierre syndrome : Individual patient-level analysis
- Contribution to journal › Letter
-
Mark
Bacterial infections in acute pancreatitis
- Contribution to journal › Letter
-
Mark
Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months : follow-up of a longitudinal clinical study
- Contribution to journal › Letter
-
Mark
COVID-19 and ANCA-associated vasculitis : Recommendations for vaccine preparedness and the use of rituximab
- Contribution to journal › Letter
-
Mark
Response to Letter to the Editor : ‘Comments on the paper presenting prediction models for incident hand OA in the HUNT study’
- Contribution to journal › Letter
